Sitemap | Pharmaceutical Business Review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

Category: Contracts

Jan 23, 2025 » Kamada to supply immune globulin products in Latin America
Aug 09, 2024 » Bavarian Nordic secures $156.8m US vaccine deal
Dec 14, 2022 » Boehringer Ingelheim receives EC conditional marketing approval for spesolimab
Nov 18, 2022 » Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology
Nov 11, 2022 » Harbour BioMed, Moderna partner on immunotherapies development

Category: Deals

Jan 20, 2025 » Fermion and Simcere to partner on development of pain treatment drug
Dec 31, 2024 » WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery
Jul 15, 2024 » Merck enhances ophthalmology portfolio with EyeBio acquisition
Apr 18, 2024 » Biocon signs licensing and supply deal for diabetes drug in Brazil
Mar 26, 2024 » Q32 Bio concludes merger deal with Homology Medicines

Category: News

Oct 23, 2026 » Boehringer and Microsoft collaborate to explore AI in clinical research
Oct 23, 2026 » Celltrion and Kaigene sign $580m licence deal for KG013
Oct 22, 2026 » Astellas and AI Proteins sign miniprotein therapeutics deal
Oct 22, 2026 » MSD’s Keytruda and Padcev combination receives EC approval
Oct 21, 2026 » FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease

Category: Uncategorized

Jun 26, 2026 » Immunai and Boehringer partner to identify T-cell targets
Jun 25, 2026 » RQ Bio secures $115m to develop influenza antibody programme
Apr 28, 2026 » FDA approves AstraZeneca’s Saphnelo for SLE
Dec 01, 2020 » SAB Biotherapeutics awarded $57.5m from BARDA and US Department of Defense for SAB-185
Aug 17, 2020 » Chugai’s Enspryng receives regulatory approval from FDA for neuromyelitis optica spectrum disorder

Industry Taxonomy: Packaging & Supply Chain

Feb 11, 2021 » AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability
Jan 21, 2021 » Akron Biotech to exclusively manufacture Human AB Serum for Octapharma
Dec 05, 2019 » AWS announces strategic collaboration with Novartis to accelerate digital transformation of its business operations
Mar 11, 2019 » Nallian to launch global pharma tracker for temperature-controlled shipments
Feb 07, 2019 » PCI Pharma announces bottling line expansion at Rockford site

Industry Taxonomy: Production & Sales

Oct 12, 2026 » FDA approves Asahi Kasei’s Hovilpri for refractory HSV
Sep 07, 2026 » AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario
Aug 10, 2026 » Innovent and Daiichi Sankyo sign deal for Vanflyta in China
Jul 09, 2026 » Sino and AstraZeneca sign licence agreement for TQC3721
Jun 08, 2026 » EC grants marketing authorisation for IntraBio’s Aqneursa

Industry Taxonomy: Clinical Trials

Oct 23, 2026 » Boehringer and Microsoft collaborate to explore AI in clinical research
Sep 10, 2026 » TwoStep Therapeutics secures $62.5m funding to advance TS-104
Mar 05, 2026 » Affinia receives FDA fast track designation for AFTX-201
Nov 06, 2025 » Leukogene Therapeutics gains FDA ODD status for M2T-CD33
Sep 09, 2024 » Superluminal Medicines secures $120m in Series A funding round

Industry Taxonomy: Drug Discovery

Oct 22, 2026 » Astellas and AI Proteins sign miniprotein therapeutics deal
Oct 21, 2026 » Sanofi and ScionxBio partner on mRNA therapies
Oct 16, 2026 » Transcripta Bio, Mayo Clinic join force on ALS therapies
Oct 14, 2026 » Pfizer partners with Enodia Therapeutics in $500m drug deal
Oct 13, 2026 » Southern Research secures NIH funding for drug testing hub

Industry Taxonomy: Regulation

Oct 22, 2026 » MSD’s Keytruda and Padcev combination receives EC approval
Oct 21, 2026 » FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease
Oct 19, 2026 » FDA approves Viatris’ Ryzumvi for adult presbyopia
Oct 13, 2026 » China’s NMPA clears Foresee’s Camcevi 42 mg for prostate cancer
Oct 05, 2026 » FDA approves expanded indication for Lilly’s Jaypirca